| Category | Min Lots | Shares | Amount |
|---|---|---|---|
| Retail (sNII) | 1 | 46 | ₹14,950 |
| HNI / NII | 14 | 644 | ₹2,09,300 |
| bHNI / bNII | 67 | 3,082 | ₹10,01,650 |
| Category | Sub (×) | Offered | Bid For | Amt (Cr)* |
|---|---|---|---|---|
| QIB | — | 69,42,306 (50.00%) | — | ₹22,562.50 Cr |
| NII / HNI (Total) | — | 20,82,693 (15.00%) | — | ₹6,768.75 Cr |
| Retail Investors | — | 48,59,616 (35.00%) | — | ₹15,793.75 Cr |
| Total ** | — | 1,38,84,615 (100.00%) | — | ₹451,249.99 Cr |
| Metric | 31 Mar 2025 | 31 Mar 2024 | 31 Mar 2023 |
|---|---|---|---|
| Revenue | 505.64 | 454.23 | 425.09 |
| PAT | 53.38 | 50.10 | 44.67 |
| EBITDA | 88.45 | 78.35 | 66.19 |
| Net Worth | 283.98 | 230.55 | 179.53 |
| Total Assets | 534.52 | 368.57 | 295.76 |
| Reserves | 278.26 | 224.88 | 182.36 |
| Borrowings | 222.37 | 111.13 | 89.36 |
Incorporated in October 1997, Gem Aromatics Limited manufactures speciality ingredients, including essential oils, aroma chemicals, and Value-Added Derivatives in India, with over two decades of experience. The company offers various products, from Mother Ingredients to Value-Added Derivatives.
The company's products are used in oral care, cosmetics, nutraceuticals, pharmaceuticals, wellness, pain management, and personal care.
The company provides a total of seventy products, categorized into four distinct groups, which include:
In Fiscal 2025, the company serves 225 customers and 44 international customers across 18 countries, including the Americas, Asia, Africa, and Australia.
The company sells products directly to customers on a business-to-business basis, with export sales through methods including (i) direct sales, (ii) sales via its subsidiary, Gem Aromatics LLC, in the USA, and (iii) sales through third-party agencies.
As of Mar 31, 2025, the company had an in-house R&D team of 13 scientists who pivotally implemented state-of-the-art technology that advanced our formulations in Value-Added Derivatives.
Competitive Strength